Literature DB >> 32032942

How long is the tail end of the learning curve? Results from 1000 consecutive endoscopic endonasal skull base cases following the initial 200 cases.

Iyan Younus1, Mina M Gerges2, Rafael Uribe-Cardenas2, Peter F Morgenstern2, Mahmoud Eljalby1, Abtin Tabaee3, Jeffrey P Greenfield2, Ashutosh Kacker3, Vijay K Anand3, Theodore H Schwartz2,3,4.   

Abstract

OBJECTIVE: Endoscopic endonasal approaches (EEAs) to the skull base have evolved over the last 20 years to become an essential component of a comprehensive skull base practice. Many case series show a learning curve from the earliest cases, in which the authors were inexperienced or were not using advanced closure techniques. It is generally accepted that once this learning curve is achieved, a plateau is reached with little incremental improvement. Cases performed during the early steep learning curve were eliminated to examine whether the continued improvement exists over the "tail end" of the curve.
METHODS: A prospectively acquired database of all EEA cases performed by the senior authors at Weill Cornell Medicine/NewYork-Presbyterian Hospital was reviewed. The first 200 cases were eliminated and the next 1000 consecutive cases were examined to avoid the bias created by the early learning curve.
RESULTS: Of the 1000 cases, the most common pathologies included pituitary adenoma (51%), meningoencephalocele or CSF leak repair (8.6%), meningioma (8.4%), craniopharyngioma (7.3%), basilar invagination (3.1%), Rathke's cleft cyst (2.8%), and chordoma (2.4%). Use of lumbar drains decreased from the first half to the second half of our series (p <0.05) as did the authors' use of fat alone (p <0.005) or gasket alone (p <0.005) for dural closure, while the use of a nasoseptal flap increased (p <0.005). Although mean tumor diameter was constant (on average), gross-total resection (GTR) increased from 60% in the first half to 73% in the second half (p <0.005). GTR increased for all pathologies but most significantly for chordoma (56% vs 100%, p <0.05), craniopharyngioma (47% vs 0.71%, p <0.05) and pituitary adenoma (67% vs 75%, p <0.05). Hormonal cure for secreting adenomas also increased from 83% in the first half to 89% in the second half (p <0.05). The rate of any complication was unchanged at 6.4% in the first half and 6.2% in the latter half of cases, and vascular injury occurred in only 0.6% of cases. Postoperative CSF leak occurred in 2% of cases and was unchanged between the first and second half of the series.
CONCLUSIONS: This study demonstrates that contrary to popular belief, the surgical learning curve does not plateau but can continue for several years depending on the complexity of the endpoints considered. These findings may have implications for clinical trial design, surgical education, and patient safety measures.

Entities:  

Keywords:  complication; endonasal; endoscopic; follow-up; gross-total resection; learning curve; outcomes; pituitary surgery; tail end; transsphenoidal

Mesh:

Year:  2020        PMID: 32032942     DOI: 10.3171/2019.12.JNS192600

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Update on management of craniopharyngiomas.

Authors:  Fraser Henderson; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

2.  Endoscopic endonasal odontoidectomy: a long-term follow-up results for a cohort of 21 patients.

Authors:  Federica Penner; Raffaele De Marco; Giuseppe Di Perna; Irene Portonero; Bianca Baldassarre; Diego Garbossa; Francesco Zenga
Journal:  Eur Spine J       Date:  2022-07-20       Impact factor: 2.721

3.  Minimally Invasive Approaches to Anterior Skull Base Meningiomas.

Authors:  Scott C Seaman; Muhammad S Ali; Anthony Marincovich; Luyuan Li; Jarrett E Walsh; Jeremy D W Greenlee
Journal:  J Neurol Surg B Skull Base       Date:  2020-12-29

4.  Learning curve and influencing factors of performing microsurgical anastomosis: a laboratory prospective study.

Authors:  Etienne Lefevre; Mario Ganau; Ismail Zaed; Guaracy de Macedo Machado-Filho; Antonino Scibilia; Charles-Henry Mallereau; Damien Bresson; Julien Todeschi; Helene Cebula; Francois Proust; Jean-Luc Vignes; Alain-Charles Masquelet; Sybille Facca; Philippe Livernaux; Alex Alfieri; Taise Cruz Mosso Ramos; Marcelo Magaldi; Carmen Bruno; Salvatore Chibbaro
Journal:  Neurosurg Rev       Date:  2022-09-06       Impact factor: 2.800

5.  Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas.

Authors:  David Netuka; Andre Grotenhuis; Nicolas Foroglou; Francesco Zenga; Sebastien Froehlich; Florian Ringel; Nicolas Sampron; Nick Thomas; Martin Komarc; Martin Majovsky
Journal:  Int J Endocrinol       Date:  2022-04-11       Impact factor: 2.803

6.  Avoiding Complications in Endoscopic Trans-Sphenoidal Surgery for Pituitary Adenoma: A Beginner's Perspective.

Authors:  Pawan Goyal; Aditya Gupta; Sanjeev Srivastava; Shilpi Modi
Journal:  Asian J Neurosurg       Date:  2020-12-21

7.  Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 Patients.

Authors:  Laura Van Gerven; Zhen Qian; Anastasiya Starovoyt; Mark Jorissen; Jeroen Meulemans; Johannes van Loon; Steven De Vleeschouwer; Julie Lambert; Marie Bex; Vincent Vander Poorten
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

8.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

9.  Endoscopic transsphenoidal surgery for non-functioning pituitary adenoma: Learning curve and surgical results in a prospective series during initial experience.

Authors:  Julien Boetto; Irina Joitescu; Isabelle Raingeard; Sam Ng; Marine Le Corre; Nicolas Lonjon; Louis Crampette; Valentin Favier
Journal:  Front Surg       Date:  2022-08-02

10.  Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base Chordoma.

Authors:  Adam L Holtzman; Ronny L Rotondo; Michael S Rutenberg; Daniel J Indelicato; Alexandra De Leo; Dinesh Rao; Jeet Patel; Christopher G Morris; William M Mendenhall
Journal:  Int J Part Ther       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.